TTOO Free Cash Flow from 2010 to 2024

TTOO Stock  USD 0.57  0.07  14.00%   
T2 Biosystms Free Cash Flow yearly trend continues to be very stable with very little volatility. Free Cash Flow is likely to drop to about -50.7 M. Free Cash Flow is the amount of cash T2 Biosystms generates after accounting for cash outflows to support operations and maintain its capital assets. View All Fundamentals
 
Free Cash Flow  
First Reported
2013-03-31
Previous Quarter
-9.2 M
Current Value
-6.3 M
Quarterly Volatility
M
 
Yuan Drop
 
Covid
Check T2 Biosystms financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among T2 Biosystms' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 4.9 M or Total Revenue of 9.8 M, as well as many indicators such as Price To Sales Ratio of 2.16, Dividend Yield of 0.0 or Days Sales Outstanding of 131. TTOO financial statements analysis is a perfect complement when working with T2 Biosystms Valuation or Volatility modules.
  
Check out the analysis of T2 Biosystms Correlation against competitors.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

Latest T2 Biosystms' Free Cash Flow Growth Pattern

Below is the plot of the Free Cash Flow of T2 Biosystms over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. T2 Biosystms' Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in T2 Biosystms' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow10 Years Trend
Slightly volatile
   Free Cash Flow   
       Timeline  

TTOO Free Cash Flow Regression Statistics

Arithmetic Mean(37,160,027)
Coefficient Of Variation(40.44)
Mean Deviation12,827,751
Median(44,019,000)
Standard Deviation15,027,950
Sample Variance225.8T
Range38.3M
R-Value(0.82)
Mean Square Error80.3T
R-Squared0.67
Significance0.0002
Slope(2,749,871)
Total Sum of Squares3161.7T

TTOO Free Cash Flow History

2024-50.7 M
2023-48.3 M
2022-51 M
2021-39.3 M
2020-44 M
2019-46.1 M
2018-40.7 M

Other Fundumenentals of T2 Biosystms

T2 Biosystms Free Cash Flow component correlations

About T2 Biosystms Financial Statements

T2 Biosystms investors utilize fundamental indicators, such as Free Cash Flow, to predict how TTOO Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Free Cash Flow-48.3 M-50.7 M
Free Cash Flow Yield(2.95)(2.80)
Free Cash Flow Per Share(18.52)(19.44)
EV To Free Cash Flow(1.04)(1.09)
Price To Free Cash Flows Ratio(0.34)(0.36)
Free Cash Flow Operating Cash Flow Ratio 1.00  1.16 
When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:
Check out the analysis of T2 Biosystms Correlation against competitors.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.03)
Revenue Per Share
0.999
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.90)
Return On Equity
(6.22)
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.